Term: evolocumab
IPA: ˌɛv.əˈlɑk.jəˌmæb

==English==
{{wp}}

===Etymology===
From {{af|en||-c-|-umab|t2=cardiovascular|t3=human monoclonal antibody}}.

{{rfe|en}}

===Pronunciation===
* {{IPA|en|/ˌɛv.əˈlɑk.jəˌmæb/|a=GA}}

===Noun===
{{en-noun|-}}

# {{lb|en|pharmaceutical drug}} A [[human]] [[monoclonal antibody]] designed for the treatment of [[hyperlipidemia]].
#* {{quote-journal|en|date=July 24, 2015|author=Andrew Pollack|title=New Drug Sharply Lowers Cholesterol, but It’s Costly|work=New York Times|url=http://www.nytimes.com/2015/0